John P Sharp Insider Trading $LGND LIGAND PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for John P Sharp.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of John P Sharp. John P Sharp is VP Finance and CFO in LIGAND PHARMACEUTICALS INC ($LGND).

John P Sharp in LIGAND PHARMACEUTICALS INC

Trading Symbol: LGND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John P Sharp: VP Finance and CFO
Holdings: 17,667 shares
Current Value: $1,905,209
Latest Transaction: Feb 14 2014
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of John P Sharp in LIGAND PHARMACEUTICALS INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	21.92	4,584	100,481	10,984
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	21.00	1,166	24,486	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	16.14	1,000	16,140	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	14.47	14,622	211,580	8,582
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	10.05	6,086	61,164	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	9.96	7,495	74,650	347
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	40.86	8,333	340,486	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	21.00	6,012	126,252	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	21.00	7,321	153,741	6,012
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	16.14	16,666	268,989	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	14.47	2,879	41,659	8,917
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	10.05	10,789	108,429	13,125
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	7,495	556,654	17,667	25.2 K to 17.7 K (-29.79 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	9.96	7,495	74,650	25,162	17.7 K to 25.2 K (+42.42 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	4,584	340,454	17,667	22.3 K to 17.7 K (-20.60 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	21.92	4,584	100,481	22,251	17.7 K to 22.3 K (+25.95 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	14,622	1,085,976	17,667	32.3 K to 17.7 K (-45.28 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	14.47	14,622	211,580	32,289	17.7 K to 32.3 K (+82.76 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	75.73	2,879	218,027	17,667	20.5 K to 17.7 K (-14.01 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	14.47	2,879	41,659	20,546	17.7 K to 20.5 K (+16.30 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	75.73	10,789	817,051	17,667	28.5 K to 17.7 K (-37.91 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	10.05	10,789	108,429	28,456	17.7 K to 28.5 K (+61.07 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	6,086	452,007	17,667	23.8 K to 17.7 K (-25.62 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	10.05	6,086	61,164	23,753	17.7 K to 23.8 K (+34.45 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	75.73	6,012	455,289	17,667	23.7 K to 17.7 K (-25.39 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	21.00	6,012	126,252	23,679	17.7 K to 23.7 K (+34.03 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	7,321	543,731	17,667	25 K to 17.7 K (-29.30 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	21.00	7,321	153,741	24,988	17.7 K to 25 K (+41.44 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	75.73	8,333	631,058	17,667	26 K to 17.7 K (-32.05 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	40.86	8,333	340,486	26,000	17.7 K to 26 K (+47.17 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	1,000	74,270	17,667	18.7 K to 17.7 K (-5.36 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	16.14	1,000	16,140	18,667	17.7 K to 18.7 K (+5.66 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	16,666	1,237,784	17,667	34.3 K to 17.7 K (-48.54 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	16.14	16,666	268,989	34,333	17.7 K to 34.3 K (+94.33 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	1,166	86,599	17,667	18.8 K to 17.7 K (-6.19 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	21.00	1,166	24,486	18,833	17.7 K to 18.8 K (+6.60 %)
Dec 16 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	9.96	700	6,972	7,842
Dec 16 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	53.44	700	37,408	17,667	18.4 K to 17.7 K (-3.81 %)
Dec 16 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	9.96	700	6,972	18,367	17.7 K to 18.4 K (+3.96 %)
Dec 09 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	56.08	6,000	336,480	17,667	23.7 K to 17.7 K (-25.35 %)
Nov 20 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	9.96	624	6,215	8,542
Nov 20 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	53.00	1,123	59,519	23,667	24.8 K to 23.7 K (-4.53 %)
Nov 20 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	9.96	624	6,215	24,790	24.2 K to 24.8 K (+2.58 %)
Aug 20 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	9.96	7,500	74,700	9,166
Aug 20 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	42.75	7,500	320,619	24,166	31.7 K to 24.2 K (-23.68 %)
Aug 20 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	9.96	7,500	74,700	31,666	24.2 K to 31.7 K (+31.04 %)
Feb 19 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	A	21.92	15,568	341,251	15,568
Feb 19 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	A	21.92	4,432	97,149	4,432
Feb 19 2013	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Grant	A	0.00	2,500	0	24,166	21.7 K to 24.2 K (+11.54 %)

Page: 1